Search research articles
Contact Us
Filters
Showing results (441-450 of 754) with videos related to
Page
of 76
Sort By:
Neuro-Oncology
|
May 8, 2014
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas
Matthias A Karajannis, Geneviève Legault, Michael J Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201
Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, et al.
Scientific Reports
|
April 10, 2026
Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach
Julia K Sundheimer, Julia Benzel, Aniello Federico, et al.
Clinical Genetics
|
June 17, 2026
The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics
Ian A Cree, Mark J Arends, Joseph D Khoury, et al.
Acta Neuropathologica Communications
|
April 27, 2019
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
H Binder, E Willscher, H Loeffler-Wirth, et al.
Neuro-Oncology
|
April 4, 2017
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain
Johannes Gojo, Daniela Lötsch, Sabine Spiegl-Kreinecker, et al.
The American Journal of Pathology
|
September 19, 2012
The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis
Dat T Vo, Dharmalingam Subramaniam, Marc Remke, et al.
Neuro-Oncology
|
December 17, 2020
Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study
Jonas E Adolph, Gudrun Fleischhack, Ruth Mikasch, et al.
Nature Communications
|
February 10, 2023
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability
Zaili Luo, Dazhuan Xin, Yunfei Liao, et al.
Brain Pathology (Zurich, Switzerland)
|
June 27, 2015
Papillary Tumor of the Pineal Region: A Distinct Molecular Entity
Stephanie Heim, Martin Sill, David T W Jones, et al.
Page
of 76
Search research articles
Search
Showing results (441-450 of 754) with videos related to
Sort By:
Page
of 76
Neuro-Oncology
|
May 8, 2014
Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas
Matthias A Karajannis, Geneviève Legault, Michael J Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201
Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, et al.
Scientific Reports
|
April 10, 2026
Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach
Julia K Sundheimer, Julia Benzel, Aniello Federico, et al.
Clinical Genetics
|
June 17, 2026
The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics
Ian A Cree, Mark J Arends, Joseph D Khoury, et al.
Acta Neuropathologica Communications
|
April 27, 2019
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
H Binder, E Willscher, H Loeffler-Wirth, et al.
Neuro-Oncology
|
April 4, 2017
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain
Johannes Gojo, Daniela Lötsch, Sabine Spiegl-Kreinecker, et al.
The American Journal of Pathology
|
September 19, 2012
The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis
Dat T Vo, Dharmalingam Subramaniam, Marc Remke, et al.
Neuro-Oncology
|
December 17, 2020
Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study
Jonas E Adolph, Gudrun Fleischhack, Ruth Mikasch, et al.
Nature Communications
|
February 10, 2023
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability
Zaili Luo, Dazhuan Xin, Yunfei Liao, et al.
Brain Pathology (Zurich, Switzerland)
|
June 27, 2015
Papillary Tumor of the Pineal Region: A Distinct Molecular Entity
Stephanie Heim, Martin Sill, David T W Jones, et al.
Page
of 76